Neurona Therapeutics is a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system. Founded by leading-edge neuroscientists and stem cell pioneers at the University of California, San Francisco, Neurona is driven by rigorous scientific discovery and breakthrough treatments for neurological disorders. With nearly two decades of research, Neurona believes that specific neural cell lineages have the unique ability to integrate and repair dysregulated neural circuits.

Neurona has developed a robust regenerative medicine discovery platform and proprietary methods to manufacture specific types of fully-differentiated neuronal, glial, and gene-edited cell therapy candidates. These therapies are targeted for delivery into the damaged nervous system. The company's cGMP facility ensures the highest standards for product manufacturing.

Neurona's dedicated team of innovators is focused on advancing first-in-class cell therapy treatments for patients with significant unmet medical needs. Their mission is to create safe and effective cell therapies for chronic disorders of the nervous system through rigorous science, collaborative innovation, and groundbreaking regenerative technology. With a vision to set the standard for restorative cell therapies, Neurona aims to improve the quality of life and revolutionize medical treatment for those living with chronic disorders of the nervous system